PD monitoring of antiepileptic drug therapy

Therapeutic Drug Monitoring
Christian Brandt

Abstract

Epilepsy is characterized by seizures recurring at inter-individually differing time intervals. It may be difficult to assess drug response if time intervals between seizures are long. Thus, the existence of surrogate parameters that could be used to reliably identify drug efficacy and tolerability at an early stage and also as prognostic factors would be desirable. Electroencephalography, magnetic resonance imaging and genetic markers are the domains to be assessed in this respect. The availability of clinically useful pharmacodynamic parameters is, however, currently disappointing.

References

Sep 10, 2003·Clinical Pharmacokinetics·Theodor W MayBernhard Rambeck
Oct 7, 2003·Epilepsy & Behavior : E&B·U SpechtR Thorbecke
Apr 25, 2006·Lancet Neurology·Frank G GilliamAndres M Kanner
Oct 20, 2006·Clinical Pharmacokinetics·Svein I Johannessen, Torbjörn Tomson
Feb 8, 2007·Epilepsia·Rosemary June PanelliTerence J O'Brien
Aug 19, 2007·Der Nervenarzt·C BrandtB Pohlmann-Eden
Sep 6, 2007·Neurology·D G A Kasteleijn-Nolst TrenitéE Hirsch
Jan 9, 2008·Seizure : the Journal of the British Epilepsy Association·Marianne Søndergaard KhinchiPeter Wolf
Oct 7, 2008·Seizure : the Journal of the British Epilepsy Association·Stefano ProOriano Mecarelli
Jan 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H MeierkordUNKNOWN European Federation of Neurological Societies
Apr 22, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sergiusz JóźwiakMaria Respondek-Liberska
Nov 9, 2011·Acta Neurologica Scandinavica. Supplementum·E Ben-Menachem
May 10, 2013·Epilepsia·Bernhard J SteinhoffAnke Maren Staack
Feb 13, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Richard J StabaGregory A Worrell
Apr 16, 2014·Epilepsia·Robert S FisherSamuel Wiebe
May 6, 2014·Seizure : the Journal of the British Epilepsy Association·Sita JayalakshmiSurath Mohandas
Apr 7, 2015·Epilepsy & Behavior : E&B·Christian BrandtTheodor W May
May 27, 2015·Revue neurologique·J-C CorvolL Lacomblez
Nov 7, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Long QianZhi-Cheng Gong
Dec 31, 2016·Epilepsy Research·Dorothee Kasteleijn-Nolst TreniteRonald C Reed
Jun 30, 2018·Therapeutic Drug Monitoring·Philip N PatsalosDave J Berry
Aug 11, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sara BaldassariStéphanie Baulac

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.